Report Detail

Service & Software Global Molecular Pathology Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4693243
  • |
  • 11 May, 2026
  • |
  • Global
  • |
  • 104 Pages
  • |
  • GIR
  • |
  • Service & Software

According to our (Global Info Research) latest study, the global Molecular Pathology Services market size was valued at US$ 166 million in 2025 and is forecast to a readjusted size of US$ 279 million by 2032 with a CAGR of 7.4% during review period.
Molecular Pathology Services refer to laboratory and consultative pathology services that use DNA-, RNA-, and biomarker-based testing methods to support disease diagnosis, classification, prognosis, therapy selection, and treatment monitoring. These services commonly integrate PCR, NGS, FISH, sequencing, liquid biopsy, pathology interpretation, and clinical reporting into a unified diagnostic workflow.
This report is a detailed and comprehensive analysis for global Molecular Pathology Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Pathology Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Pathology Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Pathology Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health, Exact Sciences, Eurofins, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Pathology Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid Tumor Molecular Pathology Services
Hematologic Malignancy Molecular Pathology Services
Hereditary Disease Molecular Pathology Services
Infectious Disease Molecular Testing Services
Rare Disease Molecular Pathology Services
Others
Market segment by Service Content
Single-Gene Testing Services
Targeted Panel Testing Services
Comprehensive Genomic Profiling Services
Companion Diagnostic Support Services
Pathology Consultation and Interpretation Services
Others
Market segment by Application
Hospitals and Medical Centers
Independent Clinical Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
Others
Market segment by players, this report covers
Quest Diagnostics
Labcorp
Sonic Healthcare
NeoGenomics
Foundation Medicine
Caris Life Sciences
Tempus
Guardant Health
Exact Sciences
Eurofins
Unilabs
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Pathology Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Pathology Services, with revenue, gross margin, and global market share of Molecular Pathology Services from 2021 to 2026.
Chapter 3, the Molecular Pathology Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Molecular Pathology Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Pathology Services.
Chapter 13, to describe Molecular Pathology Services research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Molecular Pathology Services by Type
    • 1.3.1 Overview: Global Molecular Pathology Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Molecular Pathology Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Solid Tumor Molecular Pathology Services
    • 1.3.4 Hematologic Malignancy Molecular Pathology Services
    • 1.3.5 Hereditary Disease Molecular Pathology Services
    • 1.3.6 Infectious Disease Molecular Testing Services
    • 1.3.7 Rare Disease Molecular Pathology Services
    • 1.3.8 Others
  • 1.4 Classification of Molecular Pathology Services by Service Content
    • 1.4.1 Overview: Global Molecular Pathology Services Market Size by Service Content: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Molecular Pathology Services Consumption Value Market Share by Service Content in 2025
    • 1.4.3 Single-Gene Testing Services
    • 1.4.4 Targeted Panel Testing Services
    • 1.4.5 Comprehensive Genomic Profiling Services
    • 1.4.6 Companion Diagnostic Support Services
    • 1.4.7 Pathology Consultation and Interpretation Services
    • 1.4.8 Others
  • 1.5 Global Molecular Pathology Services Market by Application
    • 1.5.1 Overview: Global Molecular Pathology Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Hospitals and Medical Centers
    • 1.5.3 Independent Clinical Laboratories
    • 1.5.4 Academic and Research Institutes
    • 1.5.5 Biopharmaceutical Companies
    • 1.5.6 Others
  • 1.6 Global Molecular Pathology Services Market Size & Forecast
  • 1.7 Global Molecular Pathology Services Market Size and Forecast by Region
    • 1.7.1 Global Molecular Pathology Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.7.2 Global Molecular Pathology Services Market Size by Region, (2021-2032)
    • 1.7.3 North America Molecular Pathology Services Market Size and Prospect (2021-2032)
    • 1.7.4 Europe Molecular Pathology Services Market Size and Prospect (2021-2032)
    • 1.7.5 Asia-Pacific Molecular Pathology Services Market Size and Prospect (2021-2032)
    • 1.7.6 South America Molecular Pathology Services Market Size and Prospect (2021-2032)
    • 1.7.7 Middle East & Africa Molecular Pathology Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Quest Diagnostics
    • 2.1.1 Quest Diagnostics Details
    • 2.1.2 Quest Diagnostics Major Business
    • 2.1.3 Quest Diagnostics Molecular Pathology Services Product and Solutions
    • 2.1.4 Quest Diagnostics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.2 Labcorp
    • 2.2.1 Labcorp Details
    • 2.2.2 Labcorp Major Business
    • 2.2.3 Labcorp Molecular Pathology Services Product and Solutions
    • 2.2.4 Labcorp Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Labcorp Recent Developments and Future Plans
  • 2.3 Sonic Healthcare
    • 2.3.1 Sonic Healthcare Details
    • 2.3.2 Sonic Healthcare Major Business
    • 2.3.3 Sonic Healthcare Molecular Pathology Services Product and Solutions
    • 2.3.4 Sonic Healthcare Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sonic Healthcare Recent Developments and Future Plans
  • 2.4 NeoGenomics
    • 2.4.1 NeoGenomics Details
    • 2.4.2 NeoGenomics Major Business
    • 2.4.3 NeoGenomics Molecular Pathology Services Product and Solutions
    • 2.4.4 NeoGenomics Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 NeoGenomics Recent Developments and Future Plans
  • 2.5 Foundation Medicine
    • 2.5.1 Foundation Medicine Details
    • 2.5.2 Foundation Medicine Major Business
    • 2.5.3 Foundation Medicine Molecular Pathology Services Product and Solutions
    • 2.5.4 Foundation Medicine Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Foundation Medicine Recent Developments and Future Plans
  • 2.6 Caris Life Sciences
    • 2.6.1 Caris Life Sciences Details
    • 2.6.2 Caris Life Sciences Major Business
    • 2.6.3 Caris Life Sciences Molecular Pathology Services Product and Solutions
    • 2.6.4 Caris Life Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Caris Life Sciences Recent Developments and Future Plans
  • 2.7 Tempus
    • 2.7.1 Tempus Details
    • 2.7.2 Tempus Major Business
    • 2.7.3 Tempus Molecular Pathology Services Product and Solutions
    • 2.7.4 Tempus Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Tempus Recent Developments and Future Plans
  • 2.8 Guardant Health
    • 2.8.1 Guardant Health Details
    • 2.8.2 Guardant Health Major Business
    • 2.8.3 Guardant Health Molecular Pathology Services Product and Solutions
    • 2.8.4 Guardant Health Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Guardant Health Recent Developments and Future Plans
  • 2.9 Exact Sciences
    • 2.9.1 Exact Sciences Details
    • 2.9.2 Exact Sciences Major Business
    • 2.9.3 Exact Sciences Molecular Pathology Services Product and Solutions
    • 2.9.4 Exact Sciences Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Exact Sciences Recent Developments and Future Plans
  • 2.10 Eurofins
    • 2.10.1 Eurofins Details
    • 2.10.2 Eurofins Major Business
    • 2.10.3 Eurofins Molecular Pathology Services Product and Solutions
    • 2.10.4 Eurofins Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Eurofins Recent Developments and Future Plans
  • 2.11 Unilabs
    • 2.11.1 Unilabs Details
    • 2.11.2 Unilabs Major Business
    • 2.11.3 Unilabs Molecular Pathology Services Product and Solutions
    • 2.11.4 Unilabs Molecular Pathology Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Unilabs Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Molecular Pathology Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Molecular Pathology Services by Company Revenue
    • 3.2.2 Top 3 Molecular Pathology Services Players Market Share in 2025
    • 3.2.3 Top 6 Molecular Pathology Services Players Market Share in 2025
  • 3.3 Molecular Pathology Services Market: Overall Company Footprint Analysis
    • 3.3.1 Molecular Pathology Services Market: Region Footprint
    • 3.3.2 Molecular Pathology Services Market: Company Product Type Footprint
    • 3.3.3 Molecular Pathology Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Molecular Pathology Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Molecular Pathology Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Molecular Pathology Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Molecular Pathology Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Molecular Pathology Services Consumption Value by Type (2021-2032)
  • 6.2 North America Molecular Pathology Services Market Size by Application (2021-2032)
  • 6.3 North America Molecular Pathology Services Market Size by Country
    • 6.3.1 North America Molecular Pathology Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Molecular Pathology Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Molecular Pathology Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Molecular Pathology Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Molecular Pathology Services Market Size by Country
    • 7.3.1 Europe Molecular Pathology Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Molecular Pathology Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Molecular Pathology Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Molecular Pathology Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Molecular Pathology Services Market Size by Region
    • 8.3.1 Asia-Pacific Molecular Pathology Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Molecular Pathology Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Molecular Pathology Services Consumption Value by Type (2021-2032)
  • 9.2 South America Molecular Pathology Services Consumption Value by Application (2021-2032)
  • 9.3 South America Molecular Pathology Services Market Size by Country
    • 9.3.1 South America Molecular Pathology Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Molecular Pathology Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Molecular Pathology Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Molecular Pathology Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Molecular Pathology Services Market Size by Country
    • 10.3.1 Middle East & Africa Molecular Pathology Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Molecular Pathology Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Molecular Pathology Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Molecular Pathology Services Market Drivers
  • 11.2 Molecular Pathology Services Market Restraints
  • 11.3 Molecular Pathology Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Molecular Pathology Services Industry Chain
  • 12.2 Molecular Pathology Services Upstream Analysis
  • 12.3 Molecular Pathology Services Midstream Analysis
  • 12.4 Molecular Pathology Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Molecular Pathology Services. Industry analysis & Market Report on Molecular Pathology Services is a syndicated market report, published as Global Molecular Pathology Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Molecular Pathology Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report